AFT PHARMACEUTICALS LTD NPV revenue breakdown overview

AFT PHARMACEUTICALS LTD NPV revenue for the last year amounted to 195.40 M NZD, the most of which — 195.41 M NZD — came from its highest performing source at the moment, Pharmaceutical Intellectual Property, the year earlier bringing 156.64 M NZD. The greatest contribution to the revenue figure was made by Australia — last year it brought AFT PHARMACEUTICALS LTD NPV 108.21 M NZD, and the year before that — 94.12 M NZD.